clinical trial · NCT00516737
Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081)
Organon and Co·phase3·completed·n = 207
MigraineComparator: rizatriptan benzoateComparator: Placebo
brief summary
The purpose of this study is to test the effectiveness of rizatriptan benzoate in the early treatment of an acute migraine attack.
started
Oct 3, 2007
primary completion
Apr 8, 2008
completion
Apr 8, 2008
last updated
Apr 22, 2024
official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Factorial Design Clinical Trial to Study the Efficacy and Safety of MK0462 / Rizatriptan 10 mg for the Early Treatment of Acute Migraine
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol